- Home
- FDBC vs TLSI Comparison
FDBC vs TLSI Comparison
Compare FDBC & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FDBC | TLSI |
|---|---|---|
| Founded | 1902 | 2010 |
| Country | United States | United States |
| Employees | N/A | 110 |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 262.3M | 267.1M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | FDBC | TLSI |
|---|---|---|
| Price | $43.75 | $3.87 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 3.9K | ★ 210.1K |
| Earning Date | 04-22-2026 | 03-05-2026 |
| Dividend Yield | ★ 3.93% | N/A |
| EPS Growth | ★ 35.00 | N/A |
| EPS | ★ 4.86 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $41.93 |
| Revenue Next Year | N/A | $41.75 |
| P/E Ratio | $9.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $37.00 | $3.42 |
| 52 Week High | $50.00 | $7.95 |
Technical Indicators
Market Signals| Indicator | FDBC | TLSI |
|---|---|---|
| Relative Strength Index (RSI) | 46.04 | 30.89 |
| Support Level | $42.09 | $3.79 |
| Resistance Level | $45.89 | $5.51 |
| Average True Range (ATR) | 1.19 | 0.31 |
| MACD | -0.07 | -0.07 |
| Stochastic Oscillator | 37.33 | 1.32 |
Price Performance
Historical ComparisonAbout FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.